Drug Research
Ohio State University researchers working on promising COVID-19 vaccine
An experimental vaccine under research at The Ohio State University has shown the potential to be an option moving forward in the quest to stamp out COVID-19.
Researchers have used an engineering technique that allows for manipulation of the messenger...
Drug Research
Piramal Pharma to Collaboratewith Epirium Bio on Exclusive Integrated Development & Manufacturing Program for Orphan Drugs
Piramal Pharma Solutions, a leading contract development and manufacturing organization (CDMO), today announced that the company will be partnering with Epirum Bio on an exclusivemanufacturing relationship fornew orphan drugs targeting rare diseases with high unmetneeds.
The Piramal Pharma Solutions (PPS)...
Drug Research
AbbVie, Harvard University Form Research Alliance to Address Emergent Viral Diseases
AbbVie and Harvard University announced a $30 million collaborative research alliance, launching a multi-pronged effort at Harvard Medical School (HMS) to study and develop novel therapies against emergent viral infections, with a focus on those caused by coronaviruses and...
Drug Research
Quanticate Announces new Partnership with Antev Ltd
Quanticate is pleased to partner with Antev Limited on a Phase II, Open-Label, Multicentre Study Investigating the Pharmacokinetics, Pharmacodynamics, Efficacy and Safety of Teverelix Trifluoroacetate, a GnRH antagonist, in Participants with Advanced Prostate Cancer.
Prostate cancer is one of the...
Drug Research
Catalent Signs Agreement with AstraZeneca to Expand Manufacturing Support for COVID-19 Vaccine AZD1222
Catalent, Inc., the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, announced that Catalent Cell & Gene Therapy will provide drug substance manufacturing to AstraZeneca...
Drug Research
Evotec and Novo Nordisk form strategic alliance to develop novel therapies for kidney diseases
Evotec SE and Novo Nordisk announced a strategic collaboration on the discovery and development of innovative therapeutics for patients with chronic kidney disease.
Evotec and Novo Nordisk will jointly identify and develop novel targets based on comprehensive medical and molecular...
Drug Research
Gilead Sciences and Tango Therapeutics to Expand Strategic Oncology Collaboration
Gilead Sciences, Inc. and Tango Therapeutics announced an expanded strategic collaboration focused on the discovery, development and commercialization of innovative targeted immune evasion therapies for patients with cancer.
Under the expanded multi-year collaboration, which builds on an agreement signed in...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.